Page 81 2026 PAINT THE PAPER PINK Lincoln Daily News Oct/Nov 2026 cancer. This result both highlights the need for tailored recommendations for preventing and screening for new primary cancers in breast cancer survivors based on their specific, personal risks and provides information to help establish such guidelines.” Hyuna Sung, PhD American Cancer Society Surveillance & Health Equity Science Their study, led by ACS researcher Hyuna Sung, PhD, looked at data for women who were first diagnosed with invasive breast cancer between 1992 and 2015 and who survived for a year or longer. This included 431,222 women ages 20 to 84 years. To evaluate women’s risks, they compared the risk of developing subsequent primary cancers among survivors versus the risk expected in the general population of the same age and race. Most common subsequent cancers. Sung and her colleagues found that regardless of a woman’s breast cancer hormone receptor status, survivors were more likely than the general population to be diagnosed with 7 types of cancers: Acute nonlymphocytic leukemia (ANLL) Breast cancer (This is a second breast cancer—different from the first cancer coming back.) Colon cancer Endometrial Cancer Lung cancer Oral cavity/pharynx cancer Sarcoma How hormone status and age affect risk. The researchers found that compared to the general public, breast cancer survivors had a greater risk of developing a subsequent primary cancer when their breast cancer had been: HR-negative (44% higher risk) than those with an HR-positive cancer (20% higher risk). Those with HR-negative cancers were more likely to develop ANLL and cancers of the peritoneum, breast, ovary, and lung. Diagnosed when they were between 20 and 49 years of age (70% higher risk for HR-positive and 124% higher risk for HR-negative) than for those diagnosed between the ages of 50 to 84 (11% higher risk for HR-positive and 22% higher risk for HR-negative)
RkJQdWJsaXNoZXIy MzExODA=